| 注册
首页|期刊导航|中国医学创新|氟维司群治疗绝经后转移性乳腺癌患者的效果分析

氟维司群治疗绝经后转移性乳腺癌患者的效果分析

孙龑 马雪根 钱珏

中国医学创新2024,Vol.21Issue(33):141-145,5.
中国医学创新2024,Vol.21Issue(33):141-145,5.DOI:10.3969/j.issn.1674-4985.2024.33.034

氟维司群治疗绝经后转移性乳腺癌患者的效果分析

Efficacy Analysis of Fulvestrant in the Treatment of Postmenopausal Metastatic Breast Cancer Patients

孙龑 1马雪根 1钱珏1

作者信息

  • 1. 苏州市立医院(南京医科大学附属苏州医院)药学部 江苏 苏州 215001
  • 折叠

摘要

Abstract

Objective:To investigate the effect of Fluvestrant in the treatment of postmenopausal metastatic breast cancer(MBC).Method:A retrospective analysis was performed on 92 postmenopausal MBC patients admitted to Suzhou Municipal Hospital from March 2021 to June 2023,they were divided into control group and observation group according to treatment plan,with 46 cases in each group.The control group was treated with Leuprelin Acetate Microspheres,and the observation group was treated with Leuprelin Acetate Microspheres+Fluvestrant.After 1 year of treatment,the antitumor efficacy,serum hormone level,survival time,progression-free survival time,incidence of toxic and side effects and quality of life of the two groups were evaluated.Result:The objective remission rate of observation group was higher than that of control group(P<0.05).After treatment,the levels of lipocalin-2(LCN-2)and sine oculis homeobox homolog 1(Six1)in both groups were lower than those before treatment,the scores of World Health Organization quality of life scale(WHOQOL-BREF)were higher than those before treatment,LCN-2 and Six1 in observation group were lower than those in control group,and WHOQOL-BREF score was higher than that in control group(P<0.05).The survival time and progression-free survival time of observation group were longer than those of control group(P<0.05).There was no significant difference in the incidence of toxic and side effects between the two groups(P>0.05).Conclusion:The application of Fluvestrant in the treatment of postmenopausal MBC patients can enhance the anti-tumor efficacy and good tolerance,regulate hormone levels,and achieve the therapeutic purpose of prolonging the survival cycle of patients and improving the quality of life.

关键词

氟维司群/绝经后/转移性乳腺癌/生命质量

Key words

Fulvestrant/Postmenopausal/Metastatic breast cancer/Quality of life

引用本文复制引用

孙龑,马雪根,钱珏..氟维司群治疗绝经后转移性乳腺癌患者的效果分析[J].中国医学创新,2024,21(33):141-145,5.

中国医学创新

1674-4985

访问量1
|
下载量0
段落导航相关论文